Vera Therapeutics VERA Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's shares (basic)?
- Vera Therapeutics (VERA) reported shares (basic) of 71.5M in Q1 2026.
- How has Vera Therapeutics's shares (basic) changed year-over-year?
- Vera Therapeutics's shares (basic) increased by 12.3% year-over-year, from 63.7M to 71.5M.
- What is the long-term trend for Vera Therapeutics's shares (basic)?
- Over 3 years (2022 to 2025), Vera Therapeutics's shares (basic) has grown at a 34.5% compound annual growth rate (CAGR), from 105.1M to 255.5M.
- What does shares (basic) mean?
- The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.